Zecotek Photonics Inc. (CVE:ZMS) stock is attracting investor interest
Sean Mason | May 20, 2016 | SmallCapPower
An above market price financing generator investor interest Friday, while a medical device maker plummeted on a court ruling. Here’s some small stocks making big moves on Friday, May 20, 2016 (as of 4 pm EST):
Zecotek Photonics Inc. (CVE:ZMS) shares climbed 10% to $0.265 on Friday after the developer of photonics technologies for medical, industrial and scientific markets announced that it has arranged for a non-brokered private placement of 2,250,000 units of the Company at a price of $0.30 per unit for gross proceeds of $675,000.
As well, shares of Neovasc Inc. (TSE:NVC) plunged 74% to $0.62 as the specialty medical device company said a Massachusetts jury found in favor of CardiAQ, on CardiAQ’s claims for relief for breach of contract, breach of the duty of honesty in contractual performance, and three of CardiAQ’s six asserted trade secrets, awarding US$70 million in damages.
Mezzi Holdings Inc. (CVE:MZI), meanwhile, reported that it will be launching select styles with two major North American retailers for Fall/Winter 2016. The Company added that both of these launches are test campaigns and may lead to additional larger rollouts dependent upon positive metrics being achieved. Mezzi Holdings stock moved up 39% to $0.09 following the announcement.
Ubika Research/SmallCapPower has received compensation from Zecotek Photonics to provide analyst research coverage. For full disclosure please visit here >
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.